Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Dhodapkar

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancer|July 1, 1993
Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myelomaT E Witzig, M V Dhodapkar, R A Kyle, et al.
The Journal of Experimental Medicine|February 24, 2001
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cellsM V Dhodapkar, R M Steinman, J Krasovsky, et al.
Blood|September 1, 1994
Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?M V Dhodapkar, C Y Li, J A Lust, et al.
Leukemia & Lymphoma|December 24, 1997
Treatment of AL-amyloidosis with dexamethasone plus alpha interferonM V Dhodapkar, S Jagannath, D Vesole, et al.
British Journal of Haematology|December 31, 1997
Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myelomaM V Dhodapkar, T Kelly, A Theus, et al.
Cancer|February 15, 1996
Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective clinical trialsM V Dhodapkar, J N Ingle, S S Cha, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 13, 2001
Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regionsI B Bayer-Garner, R D Sanderson, M V Dhodapkar, et al.
Leukemia|February 6, 2014
Serial exome analysis of disease progression in premalignant gammopathiesS Zhao, M Choi, C Heuck, et al.
Blood|May 16, 1998
Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiationM V Dhodapkar, E Abe, A Theus, et al.
Blood|October 15, 1994
Chronic natural killer cell lymphocytosis: a descriptive clinical studyA Tefferi, C Y Li, T E Witzig, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer|July 1, 1993
Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myelomaT E Witzig, M V Dhodapkar, R A Kyle, et al.
The Journal of Experimental Medicine|February 24, 2001
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cellsM V Dhodapkar, R M Steinman, J Krasovsky, et al.
Blood|September 1, 1994
Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?M V Dhodapkar, C Y Li, J A Lust, et al.
Leukemia & Lymphoma|December 24, 1997
Treatment of AL-amyloidosis with dexamethasone plus alpha interferonM V Dhodapkar, S Jagannath, D Vesole, et al.
British Journal of Haematology|December 31, 1997
Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myelomaM V Dhodapkar, T Kelly, A Theus, et al.
Cancer|February 15, 1996
Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective clinical trialsM V Dhodapkar, J N Ingle, S S Cha, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 13, 2001
Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regionsI B Bayer-Garner, R D Sanderson, M V Dhodapkar, et al.
Leukemia|February 6, 2014
Serial exome analysis of disease progression in premalignant gammopathiesS Zhao, M Choi, C Heuck, et al.
Blood|May 16, 1998
Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiationM V Dhodapkar, E Abe, A Theus, et al.
Blood|October 15, 1994
Chronic natural killer cell lymphocytosis: a descriptive clinical studyA Tefferi, C Y Li, T E Witzig, et al.
Pageof 3